Clinical trial
Examination of Radiographic Progression, Efficacy and Safety of Long-Term…
NCT00237419 · Rheumazentrum Ruhrgebiet, Other · Unknown status
Key facts
| NCT number | NCT00237419 |
|---|---|
| Title | Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis |
| Official title | An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort) |
| Lead sponsor | Rheumazentrum Ruhrgebiet, Other |
| Collaborators | Centocor BV Industry Trial Coordination Center, 9713 GZ Groningen PPD Development, LP |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | infliximab |
| Enrollment | 149 |
| Start date | Dec 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 3, 2008 |
| Countries | Belgium, Finland, France, Germany, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: